COVID-19 vaccination and venous thromboembolism risk in older veterans.

Peter L ElkinSteven H BrownSkyler ResendezWilmon McCrayMelissa ResnickKendria HallGillian FranklinJean M ConnorsMary Cushman

Published in: Journal of clinical and translational science (2023)

The results provide reassurance that there is only a trivial increased risk of VTE with the current US SARS-CoV-2 vaccines used in veterans older than age 45. This risk is significantly less than VTE risk among hospitalized COVID-19 patients. The risk-benefit ratio favors vaccination, given the VTE rate, mortality, and morbidity associated with COVID-19 infection.

Keyphrases

venous thromboembolism
sars cov
coronavirus disease
direct oral anticoagulants
physical activity
cardiovascular disease
risk factors
atrial fibrillation
respiratory syndrome coronavirus